CD13 is a Critical Regulator of Cell-cell Fusion in Osteoclastogenesis

BioRxiv : the Preprint Server for Biology
M. GhoshLinda H Shapiro

Abstract

In vertebrates, bone formation is dynamically controlled by the activity of two specialized cell types: the bone-generating osteoblasts and bone-degrading osteoclasts. Osteoblasts produce the soluble receptor activator of NFkB ligand (RANKL) that binds to its receptor RANK on the surface of osteoclast precursor cells to promote osteoclastogenesis, a process that involves cell-cell fusion and assembly of molecular machinery to ultimately degrade the bone. CD13 is a transmembrane aminopeptidase that is highly expressed in cells of myeloid lineage has been shown to regulate dynamin-dependent receptor endocytosis and recycling and is a necessary component of actin cytoskeletal organization. In the present study, we show that CD13-deficient mice display a normal distribution of osteoclast progenitor populations in the bone marrow, but present a low bone density phenotype. Further, the endosteal bone formation rate is similar between genotypes, indicating a defect in osteoclast-specific function in vivo. Loss of CD13 led to exaggerated in vitro osteoclastogenesis as indicated by significantly enhanced fusion of bone marrow-derived multinucleated osteoclasts in the presence of M-CSF and RANKL, resulting in abnormally large cells with ...Continue Reading

Related Concepts

Brain
Chemotaxis
Organ
Vesicle
Site
Glucose
Glucose Oxidase
Chemicals
Biomaterials
Propel

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

Nature Chemistry
Samudra SenguptaAyusman Sen
Journal of the American Pharmaceutical Association
P G COLIN, H E SILCOX
Journal of Controlled Release : Official Journal of the Controlled Release Society
Jung Seok Lee, Jan Feijen
© 2020 Meta ULC. All rights reserved